Search Results
2019 MCHRI Symposium - David Miklos
Clinical Impact of H-Y Alloimmunization by David Miklos, MD, PhD
Real-world data on axi-cel for patients with large B-cell lymphoma
David Miklos, MD, PhD, explains how ibrutinib is being studied for the treatment of GVHD
Cancer Conversations: Immunotherapy Breakthroughs for Pediatric and Lung Cancers
David Miklos, MD, PhD, describes the optimal way to use ibrutinib in the treatment of GVHD
David Miklos, MD, on developing an orphan drug for a small population of patients
CAR T cell Options for Relapsed/Refractory DLBCL
Dr. Miklos on Development Process for KTE-X19 in MCL
Managing Known CAR T-Cell Toxicities With KTE-X19
In the Know: Key Abstracts from the ASH 2021 Annual Meeting in Acute Lymphoblastic Leukemia - 3
Developments in CAR T treatments for adult patients
